Ellen Hulskotte has 20+ years of international pharmaceutical industry experience and a deep insight in preclinical and clinical drug development. As a global clinical pharmacology lead for projects in early and late phases of development she has designed and executed innovative clinical development plans and studies to milestones and budgets. She authored various clinical and regulatory documents and successfully interacted with regulatory authorities in Europe, US and Japan in writing and face-to-face. In 2018, Ellen became partner of Curare Consulting BV, a consulting company specialized in early clinical drug development of amongst others oncology compounds. Before, Ellen held several senior scientific and/or leadership positions at Merck Sharp & Dohme (MSD), Schering-Plough and Organon, and was the clinical lead at Treeway - a biotech company aiming to develop therapies for ALS. Ellen became a registered Clinical Pharmacologist at the Centre of Human Drug Research (CHDR) in Leiden and earned her PhD in Biomedical Science at the Erasmus University Rotterdam (EUR) on HIV vaccine development.